|
End-of-day quote
Shenzhen S.E.
28/10/2026
|
5-day change | 1st Jan Change | ||
| 5.520 CNY | -0.72% |
|
-1.60% | +13.58% |
Company Valuation: Tiansheng Pharmaceutical Group Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 1,507 | 1,660 | 1,679 | 1,631 | 1,444 | 1,545 |
| Change | - | 10.13% | 1.15% | -2.84% | -11.5% | 7.05% |
| Enterprise Value (EV) 1 | 1,762 | 1,653 | 1,730 | 1,764 | 1,541 | 1,624 |
| Change | - | -6.17% | 4.65% | 1.98% | -12.66% | 5.42% |
| P/E | -3.07x | -24.5x | -18.5x | -17.5x | -16.5x | -27.9x |
| PBR | 0.64x | 0.73x | 0.77x | 0.78x | 0.72x | 0.79x |
| PEG | - | 0.3x | -0.6x | -6.31x | 2.71x | 0.8x |
| Capitalization / Revenue | 1.25x | 2.25x | 2.77x | 2.82x | 2.53x | 3.01x |
| EV / Revenue | 1.46x | 2.24x | 2.85x | 3.05x | 2.7x | 3.16x |
| EV / EBITDA | -308x | 68.3x | 151x | 97.8x | 34.2x | 25.3x |
| EV / EBIT | -14.4x | -22.8x | -18.5x | -20.5x | -25.4x | -29.4x |
| EV / FCF | 9.44x | 9.13x | -46.4x | -30.5x | 26.6x | 21.1x |
| FCF Yield | 10.6% | 11% | -2.16% | -3.28% | 3.76% | 4.74% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1.543 | -0.2132 | -0.2848 | -0.2927 | -0.2749 | -0.1743 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 1,203 | 736.7 | 607 | 579.3 | 569.7 | 514.1 |
| EBITDA 1 | -5.721 | 24.22 | 11.48 | 18.03 | 45.11 | 64.11 |
| EBIT 1 | -122.6 | -72.44 | -93.65 | -85.96 | -60.56 | -55.26 |
| Net income 1 | -490.7 | -67.81 | -90.56 | -93.07 | -87.4 | -55.42 |
| Net Debt 1 | 254.5 | -6.895 | 50.92 | 132.9 | 97.19 | 78.93 |
| Reference price 2 | 4.740 | 5.220 | 5.280 | 5.130 | 4.540 | 4.860 |
| Nbr of stocks (in thousands) | 318,000 | 318,000 | 318,000 | 318,000 | 318,000 | 318,000 |
| Announcement Date | 26/4/21 | 24/4/22 | 26/4/23 | 25/4/24 | 28/4/25 | 28/4/26 |
1CNY in Million2CNY
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 265M | |
| 37.66x | 13.18x | 27.98x | 0.53% | 1,143B | |
| 39.33x | 6.61x | 18.6x | 1.99% | 647B | |
| 37.45x | 8.4x | 17.37x | 2.4% | 506B | |
| 21.46x | 5.22x | 12.98x | 2.51% | 384B | |
| 103.38x | 5.8x | 24.86x | 2.4% | 350B | |
| 21.99x | 5.69x | 13.69x | 2.94% | 293B | |
| 22.31x | 4.51x | 12.87x | 1.96% | 265B | |
| 28.42x | 7.28x | 13.03x | 2.25% | 242B | |
| -45.78x | 7.1x | 27.53x | 2.07% | 197B | |
| Average | 29.58x | 7.09x | 18.77x | 2.12% | 402.78B | |
| Weighted average by Cap. | 35.27x | 8.35x | 20.48x | 1.8% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 002872 Stock
- Valuation Tiansheng Pharmaceutical Group Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
